Activest Wealth Management’s Biogen BIIB Stock Holding History

Activest Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.78K	Buy	36 +21	+140%	+$4.02K	﹤0.01%	632
2026 Q1	$2.75K	Buy	+15	New	+$2.76K	﹤0.01%	914
2025 Q4	–	Sell	-9	Closed	-$1.26K	–	1143
2025 Q3	$1.26K	Sell	9 -34	-79%	-$4.6K	﹤0.01%	844
2025 Q2	$5.4K	Buy	+43	New	+$5.36K	﹤0.01%	537
2025 Q1	–	Sell	-1	Closed	-$143	–	1067
2024 Q4	$153	Buy	+1	New	+$169	﹤0.01%	657
2023 Q4	–	Sell	-15	Closed	-$3.85K	–	336
2023 Q3	$3.85K	Sell	15 -203	-93%	-$54.3K	﹤0.01%	240
2023 Q2	$60.4K	Buy	218 +203	+1,353%	+$60.4K	0.04%	57
2023 Q1	$4.13K	Buy	+15	New	+$4.15K	﹤0.01%	221

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Activest Wealth Management's BIIB Position: Q2 2026 in Review

Activest Wealth Management increased its Biogen (BIIB) stake by 140% in Q2 2026, buying an estimated $4.02K and bringing the position to 36 shares worth $7.78K. The position accounts for ﹤0.01% of the portfolio, ranked #632.

Activest Wealth Management first reported a position in BIIB in Q1 2023 and has held it in 8 quarters since. The position peaked at $60.4K in Q2 2023. 362 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Activest Wealth Management held 36 shares of Biogen worth $7.78K as of Q2 2026.
Activest Wealth Management bought 21 Biogen shares in Q2 2026, an estimated $4.02K.
Biogen made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #632 holding.
Activest Wealth Management first reported a position in Biogen in Q1 2023 and has held it in 8 quarters since.
Activest Wealth Management's Biogen position peaked at $60.4K in Q2 2023.
362 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.